Parameters | C, N(%) | HBV, N(%) | HCC, N(%) | HBV + HCC, N(%) | P |
---|---|---|---|---|---|
Age (years) | P = 0.161 F = 1.740 | ||||
Mean age | 33 ± 6.216 | 53.85 ± 9.582 | 55.44 ± 10.305 | 57.13 ± 9.819 | |
Age range | 37–61 | 31–71 | 30–72 | 37–72 | |
Median | Median | Median | Median | ||
51.50 years | 58 years | 56 years | 59 years | ||
Sex | P = 0.738 F = 0.413 | ||||
Male | 24(80.0) | 28(70.0) | 32(78.0) | 29(72.5) | |
Female | 6(20.0) | 12(30.0) | 9(22.0) | 11(27.5) | |
Hepatocellular carcinoma | |||||
Well or moderately differentiated | 37(90.2) | 35(87.5) | |||
Poorly differentiated | - | - | 4(9.8) | 5(12.5) | |
HCC grading | |||||
Early | 39(95.1) | 38(95.0) | |||
G1 | – | 1(2.4) | 2(5.0) | ||
G2–G3 | – | 1(2.4) | 0 | ||
Total bilirubin (μ mol/l) | 15.43 ± 5.65 | 18.76 ± 6.75 | 28.45 ± 12.24 | 33.10 ± 11.77 | |
ALT (U/L) | 26.23 ± 10.90 | 45.76 ± 32.03 | 88.25 ± 95.32 | 117.76 ± 102.54 | |
AFP (ng/mL) | 2.12 ± 1.14 | 3.12 ± 2.79 | 421.21 ± 104.33 | 534.54 ± 420.76 | |
Serum HBV DNA level | |||||
Mean, log IU/mL (1SD) | – | 7.6 ± 0.8 | – | 7.8 ± 0.1 | |
HBs-Ag positive | – | 40(100.0) | – | 40(100.0) | |
HBe-Ab positive | – | 12(30.0) | – | 15(37.5) |